Skip to main content
Caplight Logo









Cellexus

Cellexus

Private
DundeeHealthcare & Life Scienceshttps://cellexus.com/

Last Round

Strategic

Apr 2, 2024

Total Funding Raised

$480,000

Company Overview

Cellexus is a life sciences company that researches, develops, and manufactures single-use, airlift bioreactor systems and related technology.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

single-use bioreactorairlift bioreactordisposable bioreactorbioprocessing equipmentsingle-use technologySUTbioreactor manufacturercell culturemicrobial fermentationlow-shear cell culturebacteriophage amplificationairlift technologybioreactor consumablesvaccine productiongene therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellexus Comparables

Compare Cellexus with similar companies based on industry and business-model similarity.

Cellexus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stobbe Group
80%
PBS Biotech
79%
OmniBRx Biotechnologies
79%

Cellexus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicApr 2, 2024
GrantJun 3, 2021
VC RoundAug 1, 2018

Key People

Founding team and executive leadership

Gavin Hands

CEO, Company Secretary

Executive Team

Cellexus Investors

Notable investors and investment history

Cellexus investors
InvestorRounds
Innovate UKGrant
Scottish Investment Bank (Scottish Enterprise)Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors increased 48% MoM.

  • Jan 31, 2026

    Monthly visitors grew 42% MoM, reaching 2K.

Cellexus Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellexus Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellexus's valuation, stock price, and market status.

Firmographic Details

HeadquartersDundee
Employee Range7
Year Founded2017
Last FundingApr 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?